JP2024533182A5 - - Google Patents
Info
- Publication number
- JP2024533182A5 JP2024533182A5 JP2024514040A JP2024514040A JP2024533182A5 JP 2024533182 A5 JP2024533182 A5 JP 2024533182A5 JP 2024514040 A JP2024514040 A JP 2024514040A JP 2024514040 A JP2024514040 A JP 2024514040A JP 2024533182 A5 JP2024533182 A5 JP 2024533182A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- pharmaceutically acceptable
- disease
- disorder
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163240125P | 2021-09-02 | 2021-09-02 | |
| US63/240,125 | 2021-09-02 | ||
| PCT/US2022/042496 WO2023034589A1 (en) | 2021-09-02 | 2022-09-02 | Glun2b-subunit selective antagonists of the n-methyl-d-aspartate receptors with enhanced potency at acidic ph |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533182A JP2024533182A (ja) | 2024-09-12 |
| JP2024533182A5 true JP2024533182A5 (enExample) | 2025-09-11 |
Family
ID=85412916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024514040A Pending JP2024533182A (ja) | 2021-09-02 | 2022-09-02 | 酸性ｐＨで増強された効力を有するＮ－メチル－Ｄ－アスパラギン酸受容体のＧｌｕＮ２Ｂサブユニット選択的アンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20240360091A1 (enExample) |
| EP (1) | EP4395783A4 (enExample) |
| JP (1) | JP2024533182A (enExample) |
| CN (1) | CN118019541A (enExample) |
| AU (1) | AU2022339672B2 (enExample) |
| CA (1) | CA3230601A1 (enExample) |
| WO (1) | WO2023034589A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025255430A1 (en) * | 2024-06-07 | 2025-12-11 | Seyltx, Inc. | Compositions and methods for treating chronic cough |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002028814A2 (en) * | 2000-10-06 | 2002-04-11 | Regents Of The University Of California | Nmda receptor channel blocker with neuroprotective activity |
| WO2002072542A2 (en) | 2001-03-08 | 2002-09-19 | Emory University | Ph-dependent nmda receptor antagonists |
| US20060199864A1 (en) * | 2004-08-23 | 2006-09-07 | Traynelis Stephen F | Selection of pH-dependent compounds for in vivo therapy |
| WO2006060461A1 (en) * | 2004-12-03 | 2006-06-08 | Schering Corporation | Substituted piperazines as cb1 antagonists |
| CN103058957A (zh) * | 2007-06-29 | 2013-04-24 | 埃莫里大学 | 用于神经保护的nmda受体拮抗剂 |
| CA2704475A1 (en) | 2007-11-06 | 2009-05-14 | Emory University | Methods of identifying improved nmda receptor antagonists |
| BRPI0912362A2 (pt) * | 2008-05-09 | 2015-10-06 | Univ Emory | antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos |
| AU2010331949A1 (en) | 2009-12-15 | 2012-07-12 | Neurop, Inc. | Compounds for the treatment of neurologic disorders |
| WO2013170072A2 (en) | 2012-05-09 | 2013-11-14 | Neurop, Inc. | Compounds for the treatment of neurological disorders |
-
2022
- 2022-09-02 CN CN202280057232.3A patent/CN118019541A/zh active Pending
- 2022-09-02 JP JP2024514040A patent/JP2024533182A/ja active Pending
- 2022-09-02 WO PCT/US2022/042496 patent/WO2023034589A1/en not_active Ceased
- 2022-09-02 AU AU2022339672A patent/AU2022339672B2/en active Active
- 2022-09-02 US US18/688,300 patent/US20240360091A1/en active Pending
- 2022-09-02 CA CA3230601A patent/CA3230601A1/en active Pending
- 2022-09-02 EP EP22865618.7A patent/EP4395783A4/en active Pending
-
2024
- 2024-07-19 US US18/778,172 patent/US12415790B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024203353B2 (en) | Compositions and method of treating cancer | |
| EP3908570B1 (en) | Ketamine pamoate and use thereof | |
| RU2017119222A (ru) | Нейро-аттенуирующие кетаминовые и норкетаминовые соединения, их производные и способы их получения | |
| JP2017511339A5 (enExample) | ||
| US6833478B2 (en) | N,N-dinitramide salts as solubilizing agents for biologically active agents | |
| JPS62185017A (ja) | 変形性関節症および関連した病気の治療のためのｎ−アセチルグルコサミンの使用 | |
| JP2022549335A5 (enExample) | ||
| US2937117A (en) | Process for lowering high blood cholesterol levels | |
| CN120957718A (zh) | 任选地与n-酰基乙醇胺组合地包含n,n-二甲基色胺的组合物及其用途 | |
| JPS5910585A (ja) | スピロスクシンイミド誘導体のアルツハイマ−型痴「ほう」の治療における使用 | |
| CN121079078A (zh) | 任选地与n-酰基乙醇胺组合地包含麦角酸二乙酰胺的组合物及其用途 | |
| CN120916771A (zh) | 任选地与n-酰基乙醇胺组合地包含裸盖菇素的组合物及其用途 | |
| JPH02502185A (ja) | 咳および気管支収縮の治療用５‐ｈｔ３レセプター拮抗物質 | |
| JP2025517509A5 (enExample) | ||
| US7919486B2 (en) | Use of gallium(III) complexes for the treatment of melanomas | |
| JP2022515373A5 (enExample) | ||
| CN121793970A (zh) | Nek7激酶抑制剂的药物组合物 | |
| CN106794363A (zh) | 在单一丸剂/片剂/胶囊中米诺环素、氟康唑和阿托伐他汀在治疗多发性硬化中的用途 | |
| JPH05163145A (ja) | 脳血管性痴呆改善剤 | |
| CN120936351A (zh) | 任选地与n-酰基乙醇胺组合地包含3,4-亚甲基二氧基甲基苯丙胺的组合物及其用途 | |
| EP2912046A1 (en) | Phosphate esters of bimatoprost and the prostamides | |
| WO2002076993A1 (de) | Tumorhemmende siliciumverbindungen | |
| CA3118954C (en) | Ketamine pamoate and use thereof | |
| EP1414829A2 (de) | Tumorhemmende cerverbindungen | |
| WO2010128309A1 (en) | Combination therapy comprising a taxane and a sigma receptor ligand sauch as rimcazole |